Your browser doesn't support javascript.
loading
Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implications.
Mordant, Pierre; Grand, Bertrand; Cazes, Aurélie; Foucault, Christophe; Dujon, Antoine; Le Pimpec Barthes, Françoise; Riquet, Marc.
Afiliación
  • Mordant P; Department of General Thoracic Surgery, Georges Pompidou European Hospital, Paris Descartes University, Paris, France.
Ann Thorac Surg ; 95(4): 1189-95, 2013 Apr.
Article en En | MEDLINE | ID: mdl-23473060
ABSTRACT

BACKGROUND:

Adenosquamous carcinoma (ASC) is a mixed glandular and squamous cell carcinoma with a more aggressive behavior than the other histologic subtypes of lung cancer. We revisited the pathologic characteristics and surgical results associated with ASC.

METHODS:

Patients who underwent surgical resection of non-small cell lung cancer in two French centers were retrospectively reviewed. Patients presenting with ASC (n=141) were compared to those with adenocarcinomas (AC, n=2415) and squamous cell carcinomas (SCC, n=2662) regarding preoperative data, histologic characteristics, and outcome.

RESULTS:

The frequency of ASC and SCC decreased over time. ASC patients were similar to AC patients regarding age, sex, and smoking habits. The type of resections performed in ASC patients was intermediary between SCC (more pneumonectomy) and AC (more lobectomy) patients. ASC was associated with larger size, more frequent visceral pleura invasion, microinvasion of the lymphatic vessels, and ipsilateral second nodules, compared with SCC and AC. Among the 135 patients with documented ASC, 48% presented with a combination of AC and SCC tumor cells ranging between 40% and 60% of each component, and 55% of cases were associated with undifferentiated large cells. ASC was associated with a lower 5-year survival rate (37%) than SCC and AC (43.4% and 42.8%, respectively, p=0.017). For ASC patients, survival was better during the last decade or in cases of balanced AC/SCC components.

CONCLUSIONS:

ASC is characterized by both histologic aggressiveness and adverse prognosis. In this setting, the impact of adjuvant therapies needs to be reevaluated.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Asunto principal: Neumonectomía / Carcinoma Adenoescamoso / Neoplasias Pulmonares / Estadificación de Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Ann Thorac Surg Año: 2013 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Asunto principal: Neumonectomía / Carcinoma Adenoescamoso / Neoplasias Pulmonares / Estadificación de Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Ann Thorac Surg Año: 2013 Tipo del documento: Article País de afiliación: Francia